SCHEMBL11073535

SCHEMBL11073535

CC(NC(=O)c1ccccc1C(=O)Nc1cccnc1)C(C)(C)C

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.60
▸ ALDH1A1 P00352 5/20 0.59
▸ KDM4E B2RXH2 2/20 0.59
▸ HPGD P15428 2/20 0.59
▸ MEN1 O00255 1/20 0.59
▸ KMT2A Q03164 1/20 0.59
▸ CYP11B2 P19099 2/20 0.58
▸ HSD17B10 Q99714 2/20 0.54
▸ NPC1 O15118 5/20 0.53
▸ RAB9A P51151 5/20 0.53
▸ NAMPT P43490 4/20 0.52
▸ MAPK1 P28482 1/20 0.52
▸ HTT P42858 1/20 0.51
▸ POLB P06746 1/20 0.51
▸ SMN1; SMN2 Q16637 3/20 0.50
▸ MAPT P10636 1/20 0.50
▸ CYP11B1 P15538 1/20 0.50
▸ TP53 P04637 1/20 0.50
▸ PKM P14618 1/20 0.50
▸ TDP1 Q9NUW8 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11083276 0.85 ALDH1A1 (0.57) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL11079972 0.82 ALDH1A1 (0.59) TSHRALDH1A1MEN1KMT2ACYP11B2
SCHEMBL11075878 0.82 NAMPT (0.48) TSHRALDH1A1KDM4EHPGDMEN1
SCHEMBL11078900 0.81 NPC1 (0.60) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL11072104 0.79 ALDH1A1 (0.63) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL11072102 0.79 ALDH1A1 (0.63) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL11077042 0.79 LMNA (0.56) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL11079424 0.78 LMNA (0.56) MEN1KMT2AMAPK1POLBSMN1; SMN2
SCHEMBL18132518 0.78 ALDH1A1 (0.72) TSHRALDH1A1KDM4EHPGDMEN1
SCHEMBL9456935 0.77 ABCC9 (0.57) ALDH1A1KDM4EHPGDKMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0119428-A2 Biscarboxamides for treating diseases, and process for their preparation BAYER AG (DE) 1984-09-26 — — EP disclosed
Send feedback